CSIMarket
 
Regentis Biomaterials Ltd   (RGNT)
 

Regentis Biomaterials Ltd's Suppliers Performance

RGNT's Supply Chain




 
RGNT Costs vs Sales of Suppliers Growth

• More on RGNT Suppliers






Regentis Biomaterials Ltd's Comment on Supply Chain


The company sources critical materials and components for manufacturing GelrinC from two GMP-compliant suppliers. One primary supplier is Baxter Healthcare Corporation, with which the company has a Supply Agreement, originally established in 2008 and amended in 2009, to purchase Tisseel VHSD fibrin sealant kits through Teva Medical (Marketing) Ltd., Baxter's exclusive distributor in Israel. This Supply Agreement renews automatically each year unless terminated with notice. In addition, a Services Agreement with Baxter, initiated in 2018, provides quality, regulatory, and technical support related to the Tisseel supply, with fees based on hours of support and FDA approval status. Since March 2022, following Baxter's establishment of a local subsidiary in Israel, the company has sourced Tisseel kits directly from Baxter Israel, replacing Teva Medical (Marketing) Ltd. in the agreement without changes to the terms.

Regentis Biomaterials Ltd's Comment on Supply Chain


The company sources critical materials and components for manufacturing GelrinC from two GMP-compliant suppliers. One primary supplier is Baxter Healthcare Corporation, with which the company has a Supply Agreement, originally established in 2008 and amended in 2009, to purchase Tisseel VHSD fibrin sealant kits through Teva Medical (Marketing) Ltd., Baxter's exclusive distributor in Israel. This Supply Agreement renews automatically each year unless terminated with notice. In addition, a Services Agreement with Baxter, initiated in 2018, provides quality, regulatory, and technical support related to the Tisseel supply, with fees based on hours of support and FDA approval status. Since March 2022, following Baxter's establishment of a local subsidiary in Israel, the company has sourced Tisseel kits directly from Baxter Israel, replacing Teva Medical (Marketing) Ltd. in the agreement without changes to the terms.







RGNT's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Regentis Biomaterials Ltd 1.05 0.00 -13.65 8
SUBTOTAL 0.00 0.00 0.00 -


Sources: Regentis Biomaterials Ltd 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Regentis Biomaterials Ltd ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.